Investor Relations – Cellexon Biosystems

Partner with Cellexon – Powering India’s Biotech Future

At Cellexon Biosystems, we are transforming the landscape of transfusion medicine and diagnostics in India. With a focus on affordable innovation and local manufacturing, we invite visionary investors to join us in building a globally competitive biotech enterprise.

Why Invest in Cellexon?

• Founder-led team with 10+ years in blood banking & biotech
• End-to-end “Make in India” model: Blood Bags, Apheresis, Rapid Kits, Anti-sera
• Government scheme eligibility: MSME, CGTMSE, DPIIT, DSIR
• High-growth sector with import substitution potential
• Strong hospital network and institutional buyers
• Modular expansion plan backed by R&D and clinical partnerships
• Scalable production roadmap across Tamil Nadu & South India

Investment Opportunity

Capital Requirement: ₹10 – ₹25 Crores

Use of Funds:

• Expansion of manufacturing infrastructure
• Equipment procurement & automation
• Clinical trials and regulatory approvals (CDSCO, ISO, CE, etc.)
• Working capital for raw materials & staffing
• Product development for new biotech innovations

Open for:

• Equity Partnerships
• Convertible Instruments
• Strategic Collaborations
• Revenue-Linked or Royalty-Based Investments

Let’s Build Together

We’re actively seeking growth-minded investors, strategic partners, and biotech collaborators.

Investor Enquiry Form